Biblio
Autoimmune manifestations in VEXAS: Opportunities for integration and pitfalls to interpretation. J Allergy Clin Immunol. 2023.
. .
Germline DDX41 mutations cause ineffective hematopoiesis and myelodysplasia. Cell Stem Cell. 2021.
How I Manage Transplant Ineligible Patients with Myelodysplastic Neoplasms. Clin Hematol Int. 2022.
. Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantation. Blood. 2023.
Inequalities in the career pathway for paediatric HSCT and cellular therapy physicians. Lancet Haematol. 2023;10(7):e492-e494.